FiEE, Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results
Full-Year Revenue Growth of 867.9% Year-over-Year Achieved Net Income Turnaround in Fiscal Year 2025 HONG KONG, March 21, 2026 /PRNewswire/ -- FiEE, Inc. (NASDAQ:FIEE) ("FiEE" or the "Company"), a technology company integrating IoT, connectivity and...
Ten Pao Group Announces 2025 Annual Results
Revenue Increased 3.2% to HK$5,558.6 million, with Rising Dividend Payout to 34.7% Industrial and Consumer Power Supply Businesses Recorded Solid Growth, Supported by Expanding Global Manufacturing Capabilities Financial highlights For the year...
Everbright Environment Announces 2025 Annual Results
HONG KONG, March 20, 2026 /PRNewswire/ -- China Everbright Environment Group Limited ("Everbright Environment" or the "Company") (257.HK) announces the consolidated results of the Company and its subsidiaries (collectively the "Group") for the year...
CNOOC Limited Announces Huang Yongzhang as Chief Executive Officer
HONG KONG, March 20, 2026 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces today that Mr. Huang Yongzhang has been appointed as the Vice Chairman, an Executive Director, the...
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development
WILMINGTON, Del., March 20, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced that it has raised $787 million in financing rounds. The investment included participation by a...
Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability
SHANGHAI and HONG KONG, March 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period ending December 31, 2025, and provided an update on recent business highlights and...
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Triple-Negative Breast Cancer of TROP2/HER3 Bispecific ADC JSKN016
SUZHOU, China, March 20, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating JSKN016, a novel TROP2/HER3 bispecific antibody-drug...
GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer
SEOUL, South Korea, March 20, 2026 /PRNewswire/ -- GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in patients with metastatic castration-resistant...
Mondevo Group Announces Phiphen International, a New International Media Partnership
Joint Venture with Award-Winning Producer Molly Conners Establishes International Media Fund and Co-Production Platform Across EMEA and APAC ABU DHABI, UAE, MILAN and NEW YORK, March 19, 2026 /PRNewswire/ -- Mondevo Group, the AI-native wealth and...
CAS Announces 2026 CAS Future Leaders
Global program equips outstanding early-career scientists with leadership skills to shape the future of science COLUMBUS, Ohio, March 19, 2026 /PRNewswire/ -- CAS, a division of the American Chemical Society (ACS) specializing in scientific...